Yuekang Xu
Xinjiang Key Laboratory Of Biological Resources And Genetic Engineering
Ueruemqi, China
Ueruemqi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
PROTAC-Engineered Protein/DNA Nanoantigen is a Potent Booster for Dendritic Cell Vaccines in Cancer Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 17, 2026
Opportunities and challenges for cancer immunotherapy based on antigen cross-presentation.
Journal: Annals of medicine
Published: February 27, 2026
Slc1a2-mediated Glutamate Transport Promotes Dendritic Cell Immunity through Sema3A-regulated Cytoskeletal Remodeling and Migration.
Journal: International journal of biological sciences
Published: January 12, 2026
PMN-MDSCs-derived exosomal S100A9 drives breast cancer progression by enhancing cancer stemness and CXCL5-mediated metastatic potential.
Journal: Cell death discovery
Published: December 07, 2025
PROTAC-based nanoantigens promote cross-presentation and trafficking of dendritic cell vaccine for enhanced antitumor efficacy.
Journal: Journal for immunotherapy of cancer
Published: November 04, 2025
Crosstalk between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and immunotherapy.
Journal: Frontiers in immunology
Published: August 24, 2025
Editorial: Community series in pathogenetic mechanism and therapeutic target for inflammation in autoimmune disease, volume II.
Journal: Frontiers in immunology
Published: June 12, 2025
Identification of Two Critical Contact Residues in a Pathogenic Epitope from Tetranectin for Monoclonal Antibody Binding and Preparation of Single-Chain Variable Fragments.
Journal: Biomolecules
Published: May 27, 2025
Regulation of dendritic cell biology by amino acids and their transporters.
Journal: Frontiers in immunology
Published: May 12, 2025
Dendritic cell-based vaccine prepared with recombinant Lactococcus lactis eukaryotic-prokaryotic dual expressing OVA enhances antitumor efficacy by both direct and cross-presentation.
Journal: International immunopharmacology
Published: April 29, 2025
Piceatannol Inhibits the Immunostimulatory Functions of Dendritic Cells and Alleviates Experimental Arthritis.
Journal: International journal of molecular sciences
Published: January 26, 2025
Last Updated: 09/26/2026